.
MergerLinks Header Logo

New Deal


Announced

Completed

A consortium of investors led a $20m Series B round in Carta Healthcare.

Financials

Edit Data
Transaction Value£19m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Acquisition

Single Bidder

machine learning

Domestic

health care

Medical Services

Venture Capital

Friendly

United States

Private

Completed

hospital

Private Equity

Minority

Synopsis

Edit

A consortium of investors, including Paramark Ventures, Frist Cressey Ventures, American College of Cardiology, Asset Management Ventures, CU Healthcare Innovation Fund, Mass General Brigham, Maverick Ventures Investment Fund, and Storm Ventures, led a $20m Series B round in Carta Healthcare, a provider of harnessing the power of clinical data. “Carta Healthcare is incredibly excited and thankful for this funding round, which will help us scale the business and further realize our mission to make healthcare more accessible, efficient, scalable, effective, and affordable for patients across the United States,” said Matt Hollingsworth, co-founder and CEO, Carta Healthcare. “We look forward to continually helping reduce the administrative burden and data entry fatigue among healthcare workers so they can spend their time and energy on research and face-to-face patient time and share best practices to improve patient outcomes,” Matt Hollingsworth, Carta Co-Founder and CEO.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US